# TCRX (Tscan Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Tscan Therapeutics, Inc. reported $5.19M in revenue and a net loss of $115.1M for the trailing twelve months ended September 30, 2026 (down 76.7% year over year), with a -2246.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/TCRX
- Markdown: https://convexityos.com/fundamentals/TCRX.md
- SEC CIK: 0001783328
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001783328&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $5.19M | -76.7% YoY |
| Operating Income | TTM | -$116.5M | -2246.8% margin |
| Net Income | TTM | -$115.1M | -2219.2% net margin |
| Diluted EPS | TTM | -$0.89 | Split-adjusted |
| Free Cash Flow | TTM | -$111.7M | -2153.3% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $73.04M | Total debt: $89.28M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $10.32M | $2.82M | $21.05M | $13.54M | $10.14M | $1.08M |
| Research & Development | $114.2M | $107.3M | $88.15M | $59.82M | $44.95M | $20.58M |
| Total Operating Expenses | $146.1M | $137.6M | $114.5M | $80.17M | $58.78M | $27.32M |
| **Operating Income** | -$135.8M | -$134.8M | -$93.46M | -$66.64M | -$48.64M | -$26.23M |
| **EBITDA** | -$132.9M | -$130.7M | -$88.06M | -$61.54M | -$45.34M | -$25.03M |
| Interest Expense | $2.77M | $3.65M | $3.76M | $1.18M | -- | -- |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- |
| **Net Income** | -$129.8M | -$127.5M | -$89.22M | -$66.22M | -$48.62M | -$26.13M |
| Basic EPS | -$1.00 | -$1.14 | -$1.36 | -$2.75 | -$4.17 | -$28.52 |
| **Diluted EPS** | -$1.00 | -$1.14 | -$1.36 | -$2.75 | -$4.17 | -$28.52 |
| Basic Shares Outstanding | 129.8M | 112.0M | 65.6M | 24.0M | 11.7M | 916.0K |
| Diluted Shares Outstanding | 129.8M | 112.0M | 65.6M | 24.0M | 11.7M | 916.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $586K | $1.05M | $982K | $2.57M | $2.51M | $3.08M | $2.17M | $665K |
| Research & Development | $25.29M | $23.40M | $21.90M | $20.04M | $31.69M | $32.63M | $29.79M | $29.35M |
| Total Operating Expenses | $33.62M | $31.54M | $30.12M | $26.43M | $39.56M | $41.73M | $38.42M | $37.38M |
| **Operating Income** | -$33.03M | -$30.49M | -$29.14M | -$23.86M | -$37.05M | -$38.65M | -$36.25M | -$36.71M |
| **EBITDA** | -$32.35M | -$29.79M | -$28.45M | -$23.14M | -$36.28M | -$37.95M | -$35.57M | -$36.00M |
| Interest Expense | $775K | $699K | $689K | $702K | $699K | $689K | $679K | $784K |
| **Net Income** | -$33.09M | -$30.36M | -$28.67M | -$22.98M | -$35.71M | -$36.95M | -$34.13M | -$35.81M |
| Basic EPS | -$0.25 | -$0.23 | -$0.22 | -- | -$0.28 | -$0.28 | -$0.26 | -- |
| **Diluted EPS** | -$0.25 | -$0.23 | -$0.22 | -- | -$0.28 | -$0.28 | -$0.26 | -- |
| Basic Shares Outstanding | 130.0M | 129.9M | 129.9M | -- | 129.8M | 129.7M | 129.7M | -- |
| Diluted Shares Outstanding | 130.0M | 129.9M | 129.9M | -- | 129.8M | 129.7M | 129.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $152.4M | $178.7M | $133.4M | $120.0M | $161.4M | $34.79M |
| Short-Term Investments | -- | $111.4M | $58.69M | -- | -- | -- |
| **Cash & Short-Term Investments** | $152.4M | $290.1M | $192.0M | $120.0M | $161.4M | $34.79M |
| **Total Current Assets** | $157.2M | $292.7M | $194.2M | $124.1M | $165.7M | $36.45M |
| Property, Plant & Equipment, Net | $8.71M | $7.24M | $7.74M | $10.10M | $11.77M | $5.66M |
| **Total Non-Current Assets** | $71.58M | $78.40M | $77.91M | $74.96M | $22.45M | $13.29M |
| **Total Assets** | $228.8M | $371.1M | $272.1M | $199.1M | $188.1M | $49.74M |
| Accounts Payable | $1.24M | $4.28M | $2.37M | $2.91M | $1.76M | $2.91M |
| Short-Term Debt | -- | -- | $3.35M | -- | -- | -- |
| Deferred Revenue (Current) | $2.62M | $11.70M | $10.14M | $3.87M | $11.41M | $10.63M |
| **Total Current Liabilities** | $18.70M | $35.96M | $29.82M | $17.30M | $21.34M | $17.45M |
| Long-Term Debt | $32.53M | $32.07M | $26.70M | $29.29M | -- | -- |
| Deferred Revenue (Non-Current) | -- | $1.25M | $5.62M | -- | $1.50M | $8.82M |
| Other Non-Current Liabilities | -- | $135K | -- | $49K | $97K | $238K |
| **Total Non-Current Liabilities** | $86.97M | $94.19M | $91.46M | $82.35M | $5.99M | $15.07M |
| **Total Liabilities** | $105.7M | $130.1M | $121.3M | $99.66M | $27.33M | $32.52M |
| **Total Debt (incl. Leases)** | $94.14M | $97.38M | $92.43M | $85.98M | $6.04M | $7.43M |
| Common Stock | -- | -- | -- | -- | -- | $1.0K |
| Retained Earnings | -$504.9M | -$375.1M | -$247.6M | -$158.4M | -$92.16M | -$43.53M |
| Accumulated Other Comp. Income | -- | $51K | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $123.1M | $241.0M | $150.9M | $99.43M | $160.8M | -$42.46M |
| Total Equity | $123.1M | $241.0M | $150.9M | $99.43M | $160.8M | -$42.46M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $73.04M | $100.2M | $128.1M | $152.4M | $169.5M | $169.4M | $154.1M | $178.7M |
| Short-Term Investments | -- | -- | -- | -- | $14.95M | $48.65M | $97.58M | $111.4M |
| **Cash & Short-Term Investments** | $73.04M | $100.2M | $128.1M | $152.4M | $184.5M | $218.0M | $251.7M | $290.1M |
| **Total Current Assets** | $76.78M | $104.4M | $132.8M | $157.2M | $188.2M | $221.1M | $254.8M | $292.7M |
| Property, Plant & Equipment, Net | $7.11M | $7.74M | $8.12M | $8.71M | $9.30M | $9.52M | $8.35M | $7.24M |
| **Total Non-Current Assets** | $64.62M | $67.05M | $69.22M | $71.58M | $74.06M | $77.43M | $77.87M | $78.40M |
| **Total Assets** | $141.4M | $171.5M | $202.0M | $228.8M | $262.2M | $298.6M | $332.7M | $371.1M |
| Accounts Payable | $1.24M | $3.12M | $2.30M | $1.24M | $6.35M | $4.54M | $4.97M | $4.28M |
| Short-Term Debt | $15.70M | $11.71M | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | $586K | $1.64M | $2.62M | $5.19M | $7.70M | $10.27M | $11.70M |
| **Total Current Liabilities** | $37.82M | $30.96M | $19.97M | $18.70M | $29.21M | $31.32M | $29.82M | $35.96M |
| Long-Term Debt | $17.27M | $21.07M | $32.65M | $32.53M | $32.41M | $32.30M | $32.18M | $32.07M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | $501K | $1.25M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $278K | $113K | $124K | $135K |
| **Total Non-Current Liabilities** | $65.57M | $71.47M | $85.10M | $86.97M | $89.00M | $90.53M | $92.69M | $94.19M |
| **Total Liabilities** | $103.4M | $102.4M | $105.1M | $105.7M | $118.2M | $121.8M | $122.5M | $130.1M |
| **Total Debt (incl. Leases)** | $89.28M | $90.89M | $92.54M | $94.14M | $95.62M | $96.70M | $97.04M | $97.38M |
| Retained Earnings | -$597.0M | -$563.9M | -$533.5M | -$504.9M | -$481.9M | -$446.2M | -$409.2M | -$375.1M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $2.0K | -$4.0K | -$4.0K | $51K |
| **Total Stockholders' Equity** | $38.01M | $69.02M | $96.92M | $123.1M | $144.0M | $176.7M | $210.2M | $241.0M |
| Total Equity | $38.01M | $69.02M | $96.92M | $123.1M | $144.0M | $176.7M | $210.2M | $241.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$129.8M | -$127.5M | -$89.22M | -$66.22M | -$48.62M | -$26.13M |
| Depreciation & Amortization | $2.90M | $4.10M | $5.40M | $5.10M | $3.30M | $1.20M |
| Stock-Based Compensation | $11.71M | $9.55M | $5.21M | $4.55M | $2.52M | $515K |
| Change in Payables | -$3.01M | $1.99M | -$52K | $528K | $10K | $1.13M |
| **Operating Cash Flow** | -$135.3M | -$110.8M | -$61.36M | -$66.50M | -$48.68M | -$3.02M |
| Capital Expenditure | -$4.41M | -$3.83M | -$3.15M | -$4.22M | -$9.94M | -$4.24M |
| **Free Cash Flow** | -$139.7M | -$114.6M | -$64.50M | -$70.73M | -$58.62M | -$7.26M |
| Purchases of Investments | -$87.47M | -$241.4M | -$77.61M | -- | -- | -- |
| **Investing Cash Flow** | $109.4M | -$52.61M | -$60.76M | -$4.22M | -$9.94M | -$4.24M |
| Common Stock Issued | -- | $33.13M | $42.41M | $193K | -- | -- |
| **Financing Cash Flow** | -$336K | $208.8M | $135.4M | $29.36M | $189.7M | $288K |
| **Net Change in Cash** | -$26.28M | $45.33M | $13.33M | -$41.37M | $131.1M | -$6.97M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$33.09M | -$30.36M | -$28.67M | -$22.98M | -$35.71M | -$36.95M | -$34.13M | -$35.81M |
| Depreciation & Amortization | $678K | $699K | $693K | $723K | $767K | $698K | $678K | $711K |
| Stock-Based Compensation | $2.08M | $2.36M | $2.46M | $2.01M | $3.01M | $3.27M | $3.41M | $2.71M |
| Change in Payables | -$1.88M | $843K | $1.04M | -$5.07M | $1.93M | -$435K | $558K | $983K |
| **Operating Cash Flow** | -$27.08M | -$27.54M | -$24.28M | -$32.00M | -$32.46M | -$33.27M | -$37.59M | -$27.41M |
| Capital Expenditure | -$41K | -$493K | -$70K | -$171K | -$1.43M | -$1.28M | -$1.53M | -$888K |
| **Free Cash Flow** | -$27.12M | -$28.03M | -$24.35M | -$32.17M | -$33.89M | -$34.55M | -$39.12M | -$28.30M |
| Purchases of Investments | -- | -- | -- | $0 | $1.0K | -$26.53M | -$60.94M | -$47.33M |
| **Investing Cash Flow** | -$41K | -$465K | -$70K | $14.83M | $32.58M | $48.44M | $13.53M | $27.29M |
| **Financing Cash Flow** | -- | -- | -- | $73K | $0 | $116K | -$525K | $45.69M |
| **Net Change in Cash** | -$27.12M | -$27.90M | -$24.35M | -$17.10M | $112K | $15.29M | -$24.58M | $45.57M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1315.4% | -4787.7% | -444.0% | -492.3% | -479.6% | -2417.8% |
| **Net Profit Margin** | -1256.8% | -4527.7% | -423.9% | -489.3% | -479.5% | -2408.0% |
| Return on Equity (ROE) | -105.4% | -52.9% | -59.1% | -66.6% | -30.2% | -- |
| Return on Assets (ROA) | -56.7% | -34.4% | -32.8% | -33.3% | -25.8% | -52.5% |
| Current Ratio | 8.41x | 8.14x | 6.51x | 7.17x | 7.76x | 2.09x |
| Quick Ratio | 8.15x | 8.07x | 6.44x | 6.94x | 7.56x | 1.99x |
| Debt to Equity | 0.76x | 0.40x | 0.61x | 0.86x | 0.04x | -- |
| **Revenue Growth (YoY)** | +266.7% | -86.6% | +55.5% | +33.5% | +834.7% | -- |
| 5Y Revenue / Share Growth | -93.3% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -2246.8% | -1695.1% | -1408.7% | -1315.4% | -1765.0% | -2072.1% | -3159.9% | -4787.7% |
| **Net Profit Margin** | -2219.2% | -1655.4% | -1360.6% | -1256.8% | -1693.0% | -1964.9% | -2974.1% | -4527.7% |
| Return on Equity (ROE) | -302.8% | -170.6% | -128.3% | -105.4% | -99.0% | -77.4% | -62.6% | -52.9% |
| Return on Assets (ROA) | -81.4% | -68.7% | -61.5% | -56.7% | -54.4% | -45.8% | -39.5% | -34.4% |
| Current Ratio | 2.03x | 3.37x | 6.65x | 8.41x | 6.44x | 7.06x | 8.55x | 8.14x |
| Quick Ratio | 1.93x | 3.23x | 6.41x | 8.15x | 6.32x | 6.96x | 8.44x | 8.07x |
| Debt to Equity | 2.35x | 1.32x | 0.95x | 0.76x | 0.66x | 0.55x | 0.46x | 0.40x |
| **Revenue Growth (YoY)** | -76.7% | -65.8% | -54.8% | +286.0% | +139.4% | +473.9% | +283.6% | -90.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
